Otto J - Search Results

1

Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors.

Lagrange JL, Médecin B, Etienne MC, Pivot X, Cassuto-Viguier E, Renée N, Thyss A, Ferrero JM, Otto J, François E, Milano G. Lagrange JL, et al. Among authors: otto j. Pharmacotherapy. 1997 Nov-Dec;17(6):1246-53. Pharmacotherapy. 1997. PMID: 9399607 Clinical Trial.

2

Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.

Schneider M, Etienne MC, Milano G, Thyss A, Otto J, Dassonville O, Mobayen H, Saudes L, Guillot T, Demard F. Schneider M, et al. Among authors: otto j. J Clin Oncol. 1995 Jul;13(7):1656-62. doi: 10.1200/JCO.1995.13.7.1656. J Clin Oncol. 1995. PMID: 7602355 Clinical Trial.

3

Renal tolerance of cisplatin in patients more than 80 years old.

Thyss A, Saudes L, Otto J, Creisson A, Gaspard MH, Dassonville O, Schneider M. Thyss A, et al. Among authors: otto j. J Clin Oncol. 1994 Oct;12(10):2121-5. doi: 10.1200/JCO.1994.12.10.2121. J Clin Oncol. 1994. PMID: 7931482 Clinical Trial.

4

[Esophageal bezoars: late complication of mediastinal radiotherapy].

Tchiknavorian X, Otto J, Lagrange JL, Thyss A. Tchiknavorian X, et al. Among authors: otto j. Presse Med. 1996 Jun 8;25(20):951. Presse Med. 1996. PMID: 8685161 French. No abstract available.

5

Splenic lymphoma with villous lymphocytes: dissociated response with fludarabin.

Tchiknavorian X, Otto J, Pivot X, Arnaud MC, Schneider M, Thyss A. Tchiknavorian X, et al. Among authors: otto j. Hematol Cell Ther. 1999 Nov;41(5):233-4. doi: 10.1007/s00282-999-0233-1. Hematol Cell Ther. 1999. PMID: 10651125 No abstract available.

6

A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage.

Chatelut E, Pivot X, Otto J, Chevreau C, Thyss A, Renée N, Milano G, Canal P. Chatelut E, et al. Among authors: otto j. Eur J Cancer. 2000 Jan;36(2):264-9. doi: 10.1016/s0959-8049(99)00266-x. Eur J Cancer. 2000. PMID: 10741287

7

A multivariate analysis for predicting cisplatin-induced delayed emesis.

Pivot X, Marghali N, Etienne MC, Bensadoun RJ, Thyss A, Otto J, François E, Renée N, Lagrange JL, Schneider M, Milano G. Pivot X, et al. Among authors: otto j. Oncol Rep. 2000 May-Jun;7(3):515-9. doi: 10.3892/or.7.3.515. Oncol Rep. 2000. PMID: 10767361

8

An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia.

Pivot X, Guardiola E, Etienne M, Thyss A, Foa C, Otto J, Schneider M, Magné N, Bensadoun RJ, Renée N, Milano G. Pivot X, et al. Among authors: otto j. Eur J Cancer. 2000 May;36(7):852-7. doi: 10.1016/s0959-8049(00)00010-1. Eur J Cancer. 2000. PMID: 10785589

9

Primary lung sarcomas: long survivors obtained with iterative complete surgery.

Magné N, Porsin B, Pivot X, Tchiknavorian X, Marcy PY, Foa C, Otto J, Schneider M, Thyss A. Magné N, et al. Among authors: otto j. Lung Cancer. 2001 Feb-Mar;31(2-3):241-5. doi: 10.1016/s0169-5002(00)00167-7. Lung Cancer. 2001. PMID: 11165403

10

Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma of unknown primary site: a phase II trial.

Guardiola E, Pivot X, Tchicknavorian X, Magne N, Otto J, Thyss A, Schneider M. Guardiola E, et al. Among authors: otto j. Am J Clin Oncol. 2001 Aug;24(4):372-5. doi: 10.1097/00000421-200108000-00012. Am J Clin Oncol. 2001. PMID: 11474265 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters